Literature DB >> 2981365

Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.

R W Ellis, P M Keller, R S Lowe, R A Zivin.   

Abstract

The genome of varicella-zoster virus (VZV) encodes at least three major glycoprotein genes. Among viral gene products, the gC gene products are the most abundant glycoproteins and induce a substantial humoral immune response (Keller et al., J. Virol. 52:293-297, 1984). We utilized two independent approaches to map the gC gene. Small fragments of randomly digested VZV DNA were inserted into a bacterial expression vector. Bacterial colonies transformed by this vector library were screened serologically for antigen expression with monoclonal antibodies to gC. Hybridization of the plasmid DNA from a gC antigen-positive clone revealed homology to the 3' end of the VZV Us segment. In addition, mRNA from VZV-infected cells was hybrid selected by a set of VZV DNA recombinant plasmids and translated in vitro, and polypeptide products were immunoprecipitated by convalescent zoster serum or by monoclonal antibodies to gC. This analysis revealed that the mRNA encoding a 70,000-dalton polypeptide precipitable by anti-gC antibodies mapped to the HindIII C fragment, which circumscribes the entire Us region. We conclude that the VZV gC glycoprotein gene maps to the 3' end of the Us region and is expressed as a 70,000-dalton primary translational product. These results are consistent with the recently reported DNA sequence of Us (A.J. Davison, EMBO J. 2:2203-2209, 1983). Furthermore, glycosylation appears not to be required for a predominant portion of the antigenicity of gC glycoproteins. We also report the tentative map assignments for eight other VZV primary translational products.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981365      PMCID: PMC254981     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Development of a live attenuated varicella vaccine.

Authors:  M Takahashi; Y Okuno; T Otsuka; J Osame; A Takamizawa
Journal:  Biken J       Date:  1975-03

2.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

3.  XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome.

Authors:  A M Dumas; J L Geelen; M W Weststrate; P Wertheim; J van der Noordaa
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  Shotgun DNA sequencing using cloned DNase I-generated fragments.

Authors:  S Anderson
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

5.  Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens.

Authors:  H J Zweerink; B J Neff
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

6.  Isolation and polypeptide characterization of varicella-zoster virus.

Authors:  Y Shemer; S Leventon-Kriss; I Sarov
Journal:  Virology       Date:  1980-10-15       Impact factor: 3.616

7.  Clinical and laboratory studies of KMcC strain live attenuated varicella virus.

Authors:  B J Neff; R E Weibel; V M Villarejos; E B Buynak; A A McLean; D H Morton; B S Wolanski; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1981-03

8.  Hybridization selection and cell-free translation of mRNA's encoded within the inverted terminal repetition of the vaccinia virus genome.

Authors:  J A Cooper; R Wittek; B Moss
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

9.  The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus.

Authors:  C Grose
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  17 in total

1.  Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells.

Authors:  Y Whang; M Silberklang; A Morgan; S Munshi; A B Lenny; R W Ellis; E Kieff
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

2.  Transcription mapping of the varicella-zoster virus genome.

Authors:  J M Ostrove; W Reinhold; C M Fan; S Zorn; J Hay; S E Straus
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

3.  DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus.

Authors:  D J McGeoch; A J Davison
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

4.  Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).

Authors:  E A Montalvo; C Grose
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1.

Authors:  G P Allen; M R Yeargan
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Varicella-zoster virus as a live vector for the expression of foreign genes.

Authors:  R S Lowe; P M Keller; B J Keech; A J Davison; Y Whang; A J Morgan; E Kieff; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants.

Authors:  J M Felser; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

8.  Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus.

Authors:  P J Provost; P M Keller; F S Banker; B J Keech; H J Klein; R S Lowe; D H Morton; A H Phelps; W J McAleer; R W Ellis
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.

Authors:  A Vafai; W N Yang
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Use of a bacterial expression vector to identify the gene encoding a major core protein of vaccinia virus.

Authors:  J P Weir; B Moss
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.